Ligand validation:6IWO

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 6IWO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6IWO_MYR_A_102	24%	56%	0.259	0.892	0.55	1.15	-	-	9	0	100%	1
6IWP_MYR_A_101	30%	56%	0.197	0.862	0.61	1.09	-	-	0	0	100%	1
6IWN_MYR_A_101	19%	55%	0.24	0.835	0.62	1.09	-	-	2	0	100%	1
5TVI_MYR_V_102	17%	68%	0.178	0.751	0.52	0.69	-	-	18	0	100%	1
9LVX_MYR_B_104	100%	70%	0.032	0.99	0.36	0.79	-	-	3	0	100%	1
4G0S_MYR_B_300	100%	64%	0.034	0.987	0.61	0.78	-	-	0	0	100%	1
3A73_MYR_A_1005	99%	46%	0.049	0.98	0.51	1.55	-	2	6	0	100%	1
8Q3D_MYR_C_101	99%	69%	0.046	0.974	0.53	0.66	-	-	0	0	100%	1
1AYM_MYR_4_4000	97%	73%	0.075	0.988	0.45	0.59	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.